Comparing robot-assisted and conventional keyhole surgery for womb removal in endometrial cancer
Compares robot-assisted and conventional keyhole surgery to remove the womb in endometrial cancer.
Key facts
- Who runs it
- Rennes University Hospital
- Where
- Lille, Limoges, Paris, Pierre-Bénite, Plérin, Rennes, Rouen, Saint-Etienne, Strasbourg, and Tours, FranceSee the 15 sites
- Trial code
- Registry title
- Medico-economic Evaluation of Robot-assisted Laparoscopy Compared With Conventional Laparoscopy in Hysterectomy for Endometrial Cancer.
- Status
- Recruiting
- People taking part
- 1,680 people, planned
- Started
- 23 Sept 2024
- Expected to end
- Mar 2028
- Type of study
- Interventional, 4 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Robot-assisted laparoscopy
- conventional laparoscopy
- Prospective cohort study
- Retrospective cohort study
- information and consent
- randomization
- Collection of socio-demographic, clinical, biological, imaging and histopathological data, treatment decision, recurrence
- Surgical data collection
- Biological data collection
- Collection of histological data from the surgical specimen
- Phone calls
- Pain assessment
- Collect of data on non-reimbursed transport
- Collect of everyday help
- Collection of the business resumption date
- SF36 questionnaire
- Questionnaire EQ5D-5L
- FIGO Stadium
- Collection of treatments (analgesics and anticoagulants up to J42, complication-related treatments, etc.)
- Collection of adjuvant treatments
- Recording of any complications, emergency room visits/unscheduled consultations, additional work stoppages to the initial one
- Collection of data
- Record updated
- 15 September 2025
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adult women with early-stage, low- or intermediate-risk endometrial cancer who are planned for a keyhole (laparoscopic) hysterectomy. It compares robot-assisted with conventional laparoscopy.
- Age
- 18 years or older
- Sex
- Women only
- Disease stage
- Low- or intermediate-risk endometrial cancer: endometrioid type, low grade (grade 1 or 2), FIGO stage I on MRI before treatment
Main reasons for not taking part
- Keyhole surgery not possible because of the anaesthesia assessment before the operation
- Operated with a robot other than an Intuitive robot (Si, X or Xi)
- Pregnant or breast-feeding
- Under legal protection or deprived of liberty
- Not covered by a French social security scheme
The registry criteria, word for word
Show all 39 criteriaShow less
Who can take part
- Patient with low-risk or intermediate-risk endometrial carcinoma (on pre-operative workup including histology on endometrial biopsy and pelvic and lumbo-aortic MRI) , i.e. patients with endometrioid-type endometrial adenocarcinoma cancer low-grade (grade 1 or 2) and pre-therapeutic FIGO stage I (FIGO classification 2023) on MRI
- Indication for minimally invasive STH (laparoscopy) given by the surgeon during the pre-op consultation
- Patient accepts the matching of pseudonymized data with the French National Health Data System (SNDS)
- Major patient
- Patient having received information on the protocol and having signed a consent form, thus accepting randomization in the robot-assisted intervention group versus conventional laparoscopy; Non Inclusion Criteria:
- Patient operated on by a surgeon with less than 30 cases of robotic surgery in the last year and/or with less than 50 cases of total robotic experience at the time of patient inclusion
- Patient refuses to participate in randomized controlled trial (refuses randomization)
- The surgeon refuses the patient's participation in the randomized controlled trial (does not wish to randomize the patient)
- The center does not have a robot
- The center does not have a laparoscopic column with fluorescence
- Person under legal protection (safeguard of justice, curatorship, guardianship) or person deprived of liberty
- Patient not affiliated to a French social security scheme
- Patient participating in another interventional trial or in Jardé off-label research that impacts study data, or in RIPH3 that impacts study data
- Pregnant or breast-feeding patient
- Patient with low-risk or intermediate-risk endometrial carcinoma (on pre-operative workup including histology on endometrial biopsy and pelvic and lumbo-aortic MRI) , i.e. patient with endometrioid-type endometrial adenocarcinoma cancer low-grade (grade 1 or 2) and pre-therapeutic FIGO stage I (FIGO classification 2023) on MRI
- Indication for minimally invasive STH (laparoscopy) given by the surgeon during the pre-op consultation
- Patient accepts the matching of pseudonymized data with the French National Health Data System (SNDS)
- Major patient
- Patient not included in randomized controlled trial because :; Patient refuses to participate in randomized controlled trial (refusing randomization); The surgeon refuses the patient's participation in the randomized controlled trial (does not wish to randomize the patient); The center does not have a robot; The center does not have a laparoscopic column with fluorescence; The surgeon does not meet the required learning curve criteria (as a reminder: ≥ 30 cases of robotic surgery in the last year and with total robotic experience ≥ 50 procedures ) at the time of patient inclusion
- Patient has been informed about the protocol and has signed a consent form; Non Inclusion Criteria:
- Person under legal protection (safeguard of justice, curatorship, guardianship) or person deprived of liberty
- Patient not affiliated to a French social security scheme
- Patient participating in another interventional trial or in Jardé off-label research that impacts study data, or in RIPH3 that impacts study data
- Pregnant or breast-feeding patient
- Patient with low-risk or intermediate-risk endometrial carcinoma (on pre-operative workup including histology on endometrial biopsy and pelvic and lumbo-aortic MRI) , i.e. patient with endometrioid-type endometrial adenocarcinoma cancer low-grade (grade 1 or 2) and pre-therapeutic FIGO stage I (FIGO classification 2023) on MRI)
- STH performed during the inclusion period of the randomized controlled trial and/or the prospective cohortat a participating center, regardless of the approach used, not included in the randomized controlled trial and in the prospective cohort
- Patient not objecting to the collection and use of her data
- Patient of legal age; Non Inclusion Criteria:
- Person under legal protection (safeguard of justice, curatorship, guardianship) or person deprived of liberty
- Patient not affiliated to a French social security scheme; Surgeons :
- Surgeon performing hysterectomy on patients included in the randomized study and/or prospective cohort
- Surgeon not objecting to the collection and use of his data; Non- inclusion Criteria:; None; First surgical assistance in the field :
- First surgical assistance in the field performing hysterectomy on patients included in the randomized study and/or prospective cohort
- First surgical assistance in the field not objecting to the collection and use of his data; Non- inclusion Criteria:; None
Who cannot take part
- Minimally invasive procedure contraindicated by pre-operative anesthesia
- Patient operated on by a robot other than one of the intuitive robot variants (Si, X and Xi); Prospective cohort:
- Minimally invasive procedure contraindicated by pre-operative anesthesia
- Patient operated on by a robot other than one of the intuitive robot variants (Si, X and Xi); Retrospective cohort:
Other criteria
- Randomized Study:
Where in France
- CHU de Lille hôpital Jeanne de FlandreLille, FranceContact: Yohan KerbageNot yet recruiting
- CHU LIMOGES, Hôpital Mère-EnfantLimoges, FranceContact: Tristan GauthierTaking people
- Hôpital BichatParis, FranceContact: Martin KoskasNot yet recruiting
- Hôpital CochinParis, FranceContact: Bruno BorgheseNot yet recruiting
- Hôpital Européen Georges PompidouParis, FranceContact: Henri AzaïsTaking people
- Hôpital Lariboisière/Hôpital Saint LouisParis, FranceContact: Cyrille HuchonNot yet recruiting
- Hopital Pitie-SalpetriereParis, FranceContact: Geoffroy CanlorbeNot yet recruiting
- Hôpital Tenon AP-HPParis, FranceContact: Yohann DabiNot yet recruiting
- Hôpital Lyon Sud - Hospices Civils de LyonPierre-Bénite, FranceContact: Pierre-Adrien BolzeTaking people
- Hôpital Privé des Côtes d'ArmorPlérin, FranceContact: Isabelle JaffréNot yet recruiting
- CHU de RennesRennes, FranceContact: Vincent LavoueTaking people
- CHU de RouenRouen, FranceContact: Morgane PerrinTaking people
- Chu de Saint EtienneSaint-Etienne, FranceContact: Céline ChauleurNot yet recruiting
- CHU de Strasbourg Hôpital de HautepierreStrasbourg, FranceContact: Cherif AkladiosNot yet recruiting
- CHU de Tours -Hôpital BretonneauTours, FranceContact: Lobna OULDAMERNot yet recruiting
About the trial
What the trial wants to find out
The standard treatment for endometrial cancer is surgery, as long as the stage of the disease and the patient's condition allow. It consists of hysterectomy (TSH) with bilateral adnexectomy. The recommended surgical approach is the minimally invasive or laparoscopic route, whose oncological safety has been demonstrated by the LAP2 study.
Read full original descriptionShow less
Since 2010 and the arrival of robotic surgery in gynaecology, the robot-assisted laparoscopic approach has gradually been used for endometrial cancer Hysterectomy.
Several studies have suggested that the cost and effectiveness of laparoscopy may vary according to the age and body mass index of the patient.
The investigators therefore hypothesise that robot-assisted laparoscopy may be more efficient than conventional laparoscopy for endometrial cancer hysterectomy in the context of an advanced learning curve in France.
The investigators therefore hypothesise that robot-assisted laparoscopy could be more efficient than conventional laparoscopy for endometrial cancer hysterectomy in the context of an advanced learning curve in France. The investigators will also test the efficiency of the surgical technique as a function of age and Body mass Index.
The 4 groups in the trial
- Randomized study: Robot-assisted laparoscopyTreatment being tested
Robot-assisted laparoscopic hysterectomy
Treatment: Robot-assisted laparoscopy, information and consent, randomization, Collection of socio-demographic, clinical, biological, imaging and histopathological data, treatment decision, recurrence, Surgical data collection, Biological data collection, Collection of histological data from the surgical specimen, Phone calls, Pain assessment, Collect of data on non-reimbursed transport, Collect of everyday help, Collection of the business resumption date, SF36 questionnaire, Questionnaire EQ5D-5L, FIGO Stadium, Collection of treatments (analgesics and anticoagulants up to J42, complication-related treatments, etc.), Collection of adjuvant treatments, and Recording of any complications, emergency room visits/unscheduled consultations, additional work stoppages to the initial one
- Randomized study: conventional laparoscopyExisting treatment, for comparison
Conventional laparoscopic hysterectomy
Treatment: conventional laparoscopy, information and consent, randomization, Collection of socio-demographic, clinical, biological, imaging and histopathological data, treatment decision, recurrence, Surgical data collection, Biological data collection, Collection of histological data from the surgical specimen, Phone calls, Pain assessment, Collect of data on non-reimbursed transport, Collect of everyday help, Collection of the business resumption date, SF36 questionnaire, Questionnaire EQ5D-5L, FIGO Stadium, Collection of treatments (analgesics and anticoagulants up to J42, complication-related treatments, etc.), Collection of adjuvant treatments, and Recording of any complications, emergency room visits/unscheduled consultations, additional work stoppages to the initial one
- Prospective cohort studyOther group
Prospective cohort study backed by randomized controlled trial (for patients not included in the trial due to surgeon refusal, absence of learning curve criteria for the surgeon or patient refusal, center unable to participate in the randomized study).
Treatment: Prospective cohort study, information and consent, Collection of socio-demographic, clinical, biological, imaging and histopathological data, treatment decision, recurrence, Surgical data collection, Biological data collection, Collection of histological data from the surgical specimen, Phone calls, Pain assessment, Collect of data on non-reimbursed transport, Collect of everyday help, Collection of the business resumption date, SF36 questionnaire, Questionnaire EQ5D-5L, FIGO Stadium, Collection of treatments (analgesics and anticoagulants up to J42, complication-related treatments, etc.), Collection of adjuvant treatments, and Recording of any complications, emergency room visits/unscheduled consultations, additional work stoppages to the initial one
- Retrospective cohort studyOther group
a retrospective cohort will be set up to provide an exhaustive overview of the approaches used for endometrial cancer, according to patient characteristics (age and BMI). It will include all patients not included in the randomized controlled trial and in the prospective cohort because the surgeon did not propose it to them, because they did not wish to be followed up for the study for 6 months, or because the surgeon considered that minimally invasive surgery was not indicated; up to a limit of 1000 inclusions.
Treatment: Retrospective cohort study, information and consent, and Collection of data
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Medico-economic Evaluation of Robot-assisted Laparoscopy Compared With Conventional Laparoscopy in Hysterectomy for Endometrial Cancer: Multicentre Randomised Controlled Trial
- Plain-language title
- Comparing robot-assisted and conventional keyhole surgery for womb removal in endometrial cancerGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Record updated
- 15 September 2025